The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Comparing the performance of six human papillomavirus tests in a screening population
Open accessAbstract
BACKGROUND: Several new assays have been developed for high-risk HPV testing of cervical samples; we compare six HPV tests in a screening population. METHODS: Residual material from liquid-based PreservCyt samples was assayed. Four tests (Hybrid Capture 2, Cobas, Abbott and Becton-Dickinson (BD)) measured HPV DNA while two used RNA (APTIMA and NorChip). RESULTS: Positivity rates ranged from 13.4 to 16.3% for the DNA-based tests with a significantly lower positivity rate for the Abbott assay. The Gen-Probe APTIMA assay was positive in 10.3% of women, which was significantly lower than all the DNA tests; the NorChip PreTect HPV-Proofer test was much lower at 5.2%. 40 CIN2+ cases were identified, of which 19 were CIN3+. All CIN3+ cases were HPV positive by all tests except for one, which was negative by the Abbott assay and five which were negative by the NorChip test. CONCLUSION: All HPV tests except NorChip showed high sensitivity for high-grade lesions positive by cytology, suggesting co-testing is unnecessary when using HPV tests. Positivity rates in cytology-negative specimens were similar for the DNA-based tests, but lower for the APTIMA test suggesting this maintains the high sensitivity of DNA tests, but with better specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“as shown by multiple previous studies, the Roche Cobas 4800 assay is known for having a relatively high sensitivity compared with other HPV assays (12, 13, 17).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cuzick, J. M., Clavel, C., Petry, K. U., Meijer, C. J. L. M., Hoyer, H., Ratnam, S., Szarewski, A., Birembaut, P. L., Kulasingam, S., Sasieni, P. D., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21955 · Cited by 1,141
Self-citationRonco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 955
Self-citationMeijer, C. J. L. M., Berkhof, J., Castle, P. E., Hesselink, A. T., Franco, E. L., Ronco, G., Arbyn, M., Bosch, F. X., Cuzick, J., Dillner, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24010 · Cited by 692
Self-citationCuzick, J. M., Arbyn, M., Sankaranarayanan, R., Tsu, V. D., Ronco, G., Mayrand, M., Dillner, J., & Meijer, C. J. L. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.019 · Cited by 645
Self-citationDillner, J., Rebolj, M., Birembaut, P., Petry, K.-U., Szarewski, A., Munk, C., de Sanjose, S., Naucler, P., Lloveras, B., Kjaer, S., et al. (2008) · BMJ · doi:10.1136/bmj.a1754 · Cited by 629
Self-citationCastle, P. E., Stoler, M. H., Wright, T. C., Sharma, A., Wright, T. L., & Behrens, C. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70188-7 · Cited by 537
Rijkaart, D., Berkhof, J. H., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W. J., Heideman, D. A. M., Kenter, G. G., Cuzick, J. M., Snijders, P. J. F., & Meijer, C. J. L. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 530
Self-citationThe ATHENA human papillomavirus study: design, methods, and baseline results
Wright, T. C., Stoler, M. H., Behrens, C. M., Apple, R. J., Derion, T., & Wright, T. L. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.07.024 · Cited by 280
Szarewski, A., Ambroisine, L., Cadman, L., Austin, J., Ho, L., Terry, G., Liddle, S., Dina, R. E., McCarthy, J. E., BUCKLEY, C. H., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0508 · Cited by 227
Self-citationClinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes
Heideman, D. A. M., Hesselink, A. T., Berkhof, J. H., van Kemenade, F. J., Melchers, W. J. G., Daalmeijer, N. F., Verkuijten, M. C. G. T., Meijer, C. J. L. M., & Snijders, P. J. F. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05552-11 · Cited by 201
Research works printed but not linked: 1
- LeBar W, Taylor S, Hook EW (2009) Reproducibility of the BD Viper System with XTR Technology (Extracted Mode) with PreservCyt Liquid Based Cytology Medium. Presented at 25th Clinical Virology Symposium: Daytona Beach, FL
Cited by
Sorted by citations
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Screening tests: a review with examples
Maxim, L. D., Niebo, R., & Utell, M. J. (2014) · Inhalation Toxicology · doi:10.3109/08958378.2014.955932 · Cited by 598
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Arbyn, M., Snijders, P. J. F., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Kocjan, B. J., & Poljak, M. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.04.015 · Cited by 275
Clinical trials of human papillomavirus vaccines and beyond
Lehtinen, M., & Dillner, J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.84 · Cited by 183
Human Papillomavirus Laboratory Testing: the Changing Paradigm
Burd, E. M. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-15 · Cited by 187
Αγοραστός, Θ., Chatzistamatiou, Κ., Katsamagkas, T., Koliopoulos, G., Daponte, A. I., Constantinidis, Τ., Constantinidis, T. C., & and the HERMES study group (2015) · PLoS ONE · doi:10.1371/journal.pone.0119755 · Cited by 139
Biomarker Panels in Ischemic Stroke
Jickling, G. C., & Sharp, F. R. (2015) · Stroke · doi:10.1161/strokeaha.114.005604 · Cited by 133
Arbyn, M., Simon, M., de Sanjosé, S., Clarke, M. A., Poljak, M., Rezhake, R., Berkhof, J. H., Nyaga, V. N., Gültekin, M., Canfell, K., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00294-7 · Cited by 130
Validation of a DNA methylation HPV triage classifier in a screening sample
Lorincz, A. T., Brentnall, A. R., Scibior‐Bentkowska, D., Reuter, C., Banwait, R., Cadman, L., Austin, J., Cuzick, J. M., & Vasiljević, N. (2016) · International Journal of Cancer · doi:10.1002/ijc.30008 · Cited by 108
Self-citationA review of the FDA-approved molecular testing platforms for human papillomavirus
Salazar, K. L., Duhon, D. J., Olsen, R. J., & Thrall, M. J. (2019) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2019.06.001 · Cited by 98
Cervical cancer screening: on the way to a shift from cytology to full molecular screening
Dijkstra, M. G., Snijders, P. J. F., Arbyn, M., Rijkaart, D., Berkhof, J. H., & Meijer, C. J. L. M. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt538 · Cited by 98
Raman spectroscopy for screening and diagnosis of cervical cancer
Lyng, F. M., Traynor, D., Ramos, I., Bonnier, F., & Byrne, H. J. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8946-1 · Cited by 95
A review of the clinical performance of the Aptima HPV assay
Haedicke, J., & Iftner, T. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.10.027 · Cited by 92
Eklund, C., Forslund, O., Wallin, K., & Dillner, J. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02453-13 · Cited by 90
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women
Rossi, P. G., Carozzi, F., Ronco, G., Allìa, E., Bisanzi, S., Gillio‐Tos, A., Marco, L. D., Rizzolo, R., Gustinucci, D., Mistro, A. D., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa105 · Cited by 92
Rebolj, M., Preisler, S., Ejegod, D. M., Rygaard, C., Lynge, E., & Bonde, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086835 · Cited by 74
Heideman, D. A. M., Hesselink, A. T., van Kemenade, F. J., Iftner, T., Berkhof, J. H., Topal, F., Agard, D., Meijer, C. J. L. M., & Snijders, P. J. F. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01517-13 · Cited by 71
Cadman, L., Reuter, C., Jitlal, M., Kleeman, M., Austin, J., Hollingworth, T., Parberry, A. L., Ashdown-Barr, L., Patel, D., Nedjai, B., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1226 · Cited by 60
Self-citationSaville, M., Hawkes, D. J., Keung, M. H. T., Ip, E. W. K., Silvers, J., Sultana, F., Malloy, M., Velentzis, L. S., l, K. C., Wrede, C. D., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104375 · Cited by 60
A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results
SCHIFFMAN, M. H., Vaughan, L. M., Raine‐Bennett, T. R., Castle, P. E., Katki, H. A., Gage, J. C., Fetterman, B. J., Befano, B., & Wentzensen, N. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.06.040 · Cited by 56
Adamson, P. C., Huchko, M. J., Moss, A. M., Kinkel, H.-F., & Medina‐Marino, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137299 · Cited by 60
Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples
Asciutto, K. C., Ernstson, A., Forslund, O., & Borgfeldt, C. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.02.002 · Cited by 58
Advances in technologies for cervical cancer detection in low-resource settings
Kundrod, K. A., Smith, C. A., Hunt, B., Schwarz, R. A., Schmeler, K. M., & Richards-Kortum, R. R. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1648213 · Cited by 57
Human Papillomavirus: Screening, Testing, and Prevention.
Quinlan, J. D. (2021) · PubMed · Cited by 58
Cook, D. A., Mei, W., Smith, L., van Niekerk, D. J., Ceballos, K. M., Franco, E. L., Coldman, A. J., Ogilvie, G. S., & Krajden, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1959-5 · Cited by 51
Marongiu, L., Godi, A., Parry, J. V., & Beddows, S. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-384 · Cited by 50
SCHIFFMAN, M. H., Boyle, S., Raine‐Bennett, T. R., Katki, H. A., Gage, J. C., Wentzensen, N., Kornegay, J. R., Apple, R. J., Aldrich, C., Erlich, H. A., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1353 · Cited by 51
Cuzick, J. M., Cadman, L., Ahmad, A. S., Ho, L., Terry, G., Kleeman, M., Lyons, D., Austin, J., Stoler, M. H., Vibat, C. R. T., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0960 · Cited by 51
Self-citationPerformance of HPV E6 / E7 mRNA assay as primary screening test: Results from the NTCC2 trial
Rossi, P. G., Ronco, G., Mancuso, P., Carozzi, F., Allìa, E., Bisanzi, S., Gillio‐Tos, A., Marco, L. D., Rizzolo, R., Gustinucci, D., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34120 · Cited by 45
Resende, J. C. P., Fregnani, J. H. T. G., Kerr, L. M., Mauad, E. C., Longatto‐Filho, A., & Scapulatempo‐Neto, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134445 · Cited by 47
Paraskevaidi, M., Cameron, S. J. S., Whelan, E., Bowden, S. J., Tzafetas, M., Mitra, A., Semertzidou, A., Athanasiou, A., Bennett, P. R., MacIntyre, D. A., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103017 · Cited by 47
Castle, P. E., Eaton, B., Reid, J., Getman, D., & Dockter, J. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03558-14 · Cited by 47
Rebolj, M., Bonde, J. H., Preisler, S., Ejegod, D. M., Rygaard, C., & Lynge, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147326 · Cited by 46
de Thurah, L., Bonde, J. H., Lam, J. U. H., & Rebolj, M. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.05.020 · Cited by 49
Eklund, C., Forslund, O., Wallin, K., & Dillner, J. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.01.016 · Cited by 46
Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers
Yoshida, H., Shiraishi, K., & Kato, T. (2021) · Cancers · doi:10.3390/cancers13246351 · Cited by 45
Cook, D. A., Smith, L., Law, J. H., Mei, W., van Niekerk, D. J., Ceballos, K. M., Gondara, L., Franco, E. L., Coldman, A. J., Ogilvie, G. S., et al. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.12.004 · Cited by 45
Agreda, P. M., Beitman, G. H., Gutierrez, E. C., Harris, J. M., Koch, K. R., LaViers, W. D., Leitch, S. V., Maus, C. E., McMillian, R. A., Nussbaumer, W. A., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00759-13 · Cited by 43
Ejegod, D. M., Junge, J., Franzmann, M., Kirschner, B., Bottari, F., Sideri, M., Sandri, M.-T., & Bonde, J. (2016) · Papillomavirus Research · doi:10.1016/j.pvr.2016.01.003 · Cited by 42
Wright, T. C., Stoler, M. H., Agreda, P. M., Beitman, G. H., Gutierrez, E. C., Harris, J. M., Koch, K. R., Kuebler, M., LaViers, W. D., Legendre, B. L., et al. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcp53kmhnrdicbl · Cited by 47
A Suggested Approach to Simplify and Improve Cervical Screening in the United States
SCHIFFMAN, M. H., & Wentzensen, N. (2015) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000170 · Cited by 43
Ejegod, D. M., Bottari, F., Pedersen, H., Sandri, M. T., & Bonde, J. H. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00508-16 · Cited by 41
Huijsmans, C. J. J., Geurts-Giele, W. R. R., Leeijen, C., Hazenberg, H. L. C. M., van Beek, J., Wild, C., van der Linden, J. C., & van den Brule, A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2961-2 · Cited by 40
Performance of the Xpert HPV assay in women attending for cervical screening
Cuzick, J. M., Cuschieri, K. S., Denton, K. J., Hopkins, M. J., Thorat, M. A., Wright, C., Cubie, H., Moore, C., Kleeman, M., Austin, J., et al. (2015) · Papillomavirus Research · doi:10.1016/j.pvr.2015.05.002 · Cited by 38
Self-citationJohnson, D. C., Bhatta, M. P., Smith, J. S., Kempf, M.-C., Broker, T. R., Vermund, S. H., Chamot, E., Aryal, S., Lhaki, P., & Shrestha, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101255 · Cited by 38
Ge, Y., Christensen, P. A., Luna, E., Armylagos, D., Schwartz, M. R., & Mody, D. R. (2017) · Cancer Cytopathology · doi:10.1002/cncy.21875 · Cited by 36
The Prognostic Value of HPV Status and p16 Expression in Patients with Carcinoma of the Anal Canal
Urgoiti, G. B. R., Gustafson, K., Klimowicz, A. C., Petrillo, S. K., Magliocco, A. M., & Doll, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108790 · Cited by 34
Oštrbenk, A., Xu, L., Arbyn, M., & Poljak, M. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01176-18 · Cited by 34
Okunade, K. S., Adejimi, A. A., John‐Olabode, S., Oshodi, Y. A., & Oluwole, A. A. (2022) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s296914 · Cited by 36
HPV mRNA Is More Specific than HPV DNA in Triage of Women with Minor Cervical Lesions
Sørbye, S. W., Fismen, S., Gutteberg, T. J., Mortensen, E., & Skjeldestad, F. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112934 · Cited by 32
A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia
Mariano, V. S., Lorenzi, A. T., Scapulatempo‐Neto, C., Stein, M. D., Resende, J. C. P., Antoniazzi, M., Villa, L. L., Levi, J. E., Longatto‐Filho, A., & Fregnani, J. H. T. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164892 · Cited by 30
Persson, M., Elfström, K. M., Wendel, S. B., Weiderpass, E., & Andersson, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090023 · Cited by 29
Ma, L., Lei, J., Ma, L., Cong, X., Wang, N., Yang, H., Liu, Q., Yu, Y., & Cao, Y. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4313-8 · Cited by 28
Kang, Z., Liu, J., Ma, C., Chen, C., Lv, X., & Chen, C. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103557 · Cited by 28
You, W., Li, S., Du, R., Zheng, J., & Shen, A. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5357 · Cited by 28
Ratnam, S., Jang, D., Gilchrist, J., Smieja, M., Poirier, A., Hatchette, T. F., Flandin, J.-F., & Chernesky, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03549-13 · Cited by 27
Hillemanns, P., Friese, K., Dannecker, C., Klug, S. J., Seifert, U., Iftner, T., Hädicke, J., Löning, T., Horn, L. C., Schmidt, D., et al. (2019) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-0818-5440 · Cited by 27
Rebolj, M., Bonde, J. H., Ejegod, D. M., Preisler, S., Rygaard, C., & Lynge, E. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.04.012 · Cited by 26
Clinical Validation of the BD Onclarity? HPV Assay Using a Non-Inferiority Test
Ejegod, D. M. (2015) · Journal of Medical Microbiology & Diagnosis · doi:10.4172/2161-0703.s3-003 · Cited by 26
Weston, G., Dombrowski, C., Harvey, M. J., Iftner, T., Kyrgiou, M., Founta, C., & Adams, E. J. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-031303 · Cited by 24
Smith, C. A., Chang, M. M., Kundrod, K. A., Novak, E. N., Parra, S. G., López, L., Mavume, C., Lorenzoni, C. F., Maza, M., Salcedo, M. P., et al. (2022) · Lab on a Chip · doi:10.1039/d2lc00885h · Cited by 25
Cho, H., Hong, J. H., Min, K., Ouh, Y., Seong, S. J., Moon, J. H., Cho, S. H., & Lee, J. K. (2020) · Cancer Research and Treatment · doi:10.4143/crt.2020.1165 · Cited by 23
Zhao, X., Wu, Q., Wang, X., Fu, Y., Zhang, X., Tian, X., Cheng, B., Lü, B., Yu, X., Lan, S., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.02.027 · Cited by 23
Veijalainen, O., Kares, S., Kujala, P. M., Vuento, R., Osuala, V., Tirkkonen, M., Luukkaala, T. H., Kholová, I., & Mäenpää, J. (2018) · Cytopathology · doi:10.1111/cyt.12652 · Cited by 24
Macedo, A. C. L., Gonçalves, J. C. N., Bavaresco, D. V., Grande, A. J., Silva, N. C., & da Rosa, M. I. (2019) · Journal of Oncology · doi:10.1155/2019/6935030 · Cited by 24
Bell, M., Verberckmoes, B., Devolder, J., Vermandere, H., Degomme, O., Guimarães, Y. M., Godoy, L. R., Ambrosino, E., Cools, P., & Padalko, E. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00081-23 · Cited by 22
“However, as shown by multiple previous studies, the Roche Cobas 4800 assay is known for having a relatively high sensitivity compared with other HPV assays (12, 13, 17).”
MethodBottari, F., Sideri, M. G., Gulmini, C., Igidbashian, S., Tricca, A., Casadio, C., Carinelli, S. G., Boveri, S., Ejegod, D. M., Bonde, J. H., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00246-15 · Cited by 22
Isidean, S. D., Coutlée, F., & Franco, E. L. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.865521 · Cited by 23
Lee, D.-H., Hwang, N. R., Lim, M. C., Yoo, C. W., Joo, J., Kim, J., Park, S., & Hwang, S. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215614036 · Cited by 22
Liu, Q., Lin, X., Lin, L., Yi, L., Li, H., & Lin, J. (2015) · The Analyst · doi:10.1039/c5an00944h · Cited by 21
Poljak, M., Oštrbenk, A., Seme, K., Šterbenc, A., Jančar, N., & Bokal, E. V. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.11.021 · Cited by 21
Nakalembe, M., Kadama-Makanga, P., Mubiru, F., Swanson, M. L., Martin, J. N., & Huchko, M. J. (2019) · Infectious Agents and Cancer · doi:10.1186/s13027-019-0230-0 · Cited by 23
Moss, S., Bailey, A. C., Cubie, H. A., Denton, K. J., Sargent, A., Muir, P., Vipond, I. B., Winder, R., & Kitchener, H. C. (2014) · Cytopathology · doi:10.1111/cyt.12210 · Cited by 19
Basu, P. S., Banerjee, D., Mittal, S., Dutta, S., Ghosh, I., Chowdhury, N., Abraham, P., Chandna, P., & Ratnam, S. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24453 · Cited by 19
Avian, A., Clemente, N., Mauro, E., Isidoro, E., Napoli, M. D., Dudine, S., Fabro, A. D., Morini, S., Perin, T., Giudici, F., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03383-x · Cited by 21
Nucleic acid‐based assays for the detection of high‐risk human papillomavirus: A technical review
Gibson, J. S. (2014) · Cancer Cytopathology · doi:10.1002/cncy.21451 · Cited by 18
Cuzick, J. M., Ahmad, A. S., Austin, J., Cadman, L., Ho, L., Terry, G., Kleeman, M., Ashdown-Barr, L., Lyons, D., Stoler, M. H., et al. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.06.015 · Cited by 18
Self-citationFT-IR combined with PSO-CNN algorithm for rapid screening of cervical tumors
Ma, Y., Liang, F., Zhu, M. H., Chen, C., Chen, C., & Lv, X. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2022.103023 · Cited by 17
Maggino, T., Sciarrone, R., Murer, B., Rossi, M. R. D., Fedato, C., Maran, M., Lorio, M., Soldà, M., Zago, F., Rossi, P. G., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.216 · Cited by 20
Jaworek, H., Koudeláková, V., Drábek, J., Vrbková, J., Zbořilová, B., Oborná, I., Brezinova, J., Marek, R., Huml, K., Vaněk, P., et al. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.07.004 · Cited by 16
Fan, S., Li, P., Ouyang, L., Yuan, T., Gong, H., Ding, Y., Luo, Z., Wu, G., Yu, M., & Zou, H. (2020) · Vaccines · doi:10.3390/vaccines8020175 · Cited by 17
Singer, A., & Khan, A. (2018) · Wiley eBooks · doi:10.1002/9781118990957.ch8 · Cited by 17
Zorzi, M., Mistro, A. D., Rossi, P. G., Laurino, L., Battagello, J., Lorio, M., Soldà, M., Gabellotti, E. M., Maran, M., Cin, A. D., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32695 · Cited by 16
Ejegod, D. M., Hansen, M., Christiansen, I. K., Pedersen, H., Quint, W. G. V., Xu, L., Arbyn, M., & Bonde, J. H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104336 · Cited by 16
Borgfeldt, C., & Forslund, O. (2019) · Journal of Virological Methods · doi:10.1016/j.jviromet.2019.04.015 · Cited by 15
Zhou, F., Chen, H., Li, M., Strickland, A. L., Zheng, W., & Zhang, X. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001800 · Cited by 15
Rossi, P. G., Bisanzi, S., Allìa, E., Mongia, A., Carozzi, F., Gillio‐Tos, A., Marco, L. D., Ronco, G., Gustinucci, D., Mistro, A. D., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01794-16 · Cited by 16
Ge, Y., Christensen, P. A., Luna, E., Armylagos, D., Xu, J., Schwartz, M. R., & Mody, D. R. (2018) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000393 · Cited by 15
Zhang, J., Yang, D., Cui, X., Liu, G., Cui, Z., Wang, C., & Piao, H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.935071 · Cited by 14
Molecular diagnosis of infectious diseases using cytological specimens
Canberk, Ş., Longatto‐Filho, A., & Schmitt, F. C. (2015) · Diagnostic Cytopathology · doi:10.1002/dc.23394 · Cited by 14
Diagnóstico microbiológico de la infección por virus del papiloma humano
Mateos‐Lindemann, M. L., Pérez‐Castro, S., Rodríguez‐Iglesias, M., & Pérez‐Gracia, M. T. (2016) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2016.05.008 · Cited by 14
Wang, J., Du, Y., Dong, J., Zhou, Y., Wang, P., Zhang, X., Chen, Y., & He, P. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.12.028 · Cited by 14
Hellsten, C., Ernstson, A., Bodelsson, G., Forslund, O., & Borgfeldt, C. (2021) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000693 · Cited by 15
Liu, S. S., Chan, K. K. L., Wei, T. N., Tse, K. Y., Ngu, S., Chu, M. M. Y., Lau, L. S. K., Cheung, A., & Ngan, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272721 · Cited by 13
Rol, M., Picconi, M. A., Ferrera, A., Sánchez, G. I., Hernández, M. D. L. L., Lineros, J., Peraza, A., Brizuela, M., Mendoza, L. P., Mongelós, P., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1006038 · Cited by 15
Tao, X., Austin, R. M., Zhang, H., Zhang, L., Xiao, J., Zhou, X., Wang, L., & Zhao, C. (2017) · Cancer Cytopathology · doi:10.1002/cncy.21914 · Cited by 14
Sørbye, S. W., Falang, B. M., & Antonsen, M. (2023) · Journal of Molecular Pathology · doi:10.3390/jmp4020008 · Cited by 13
Boehmer, G., Wang, L. E., Iftner, A., Holz, B., Haedicke, J., von Wasielewski, R., Martus, P., & Iftner, T. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0674-1 · Cited by 13
Munson, E. L., Kroeger, L., Balzer, S., Amrhein, R. D., Munson, K. L., Napierala, M., Hudspeth, R. L., & Dillon, P. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03066-13 · Cited by 13
Metadata
- Authors
- Cuzick, J., Cadman, L., Mesher, D., Austin, J., Ashdown-Barr, L., Ho, L., Terry, G., Liddle, S., Wright, C., Lyons, D., & Szarewski, A.
- Affiliations
- Queen Mary University of London (GB)
- St Mary's Hospital (GB)
- Corresponding author
- Szarewski, A
- Venue
- British Journal of Cancer
- Published
- 2013-01-31
- Volume
- 108
- Issue
- 4
- Pages
- 908-913
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC3590662
- OpenAlex
- W2076776080
- Cited by
- 211
- References
- 23
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 11 · 2023: 15 · 2022: 19 · 2021: 15 · 2020: 17 · 2019: 12 · 2018: 16 · 2017: 12 · 2016: 19 · 2015: 33 · 2014: 18 · 2013: 11
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by-nc-sa)
- Funders
- Cancer Research UK (C8162/A10406, C569/A10404)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- HPV testing, cervical cancer screening, HPV DNA test, Norchip, Hybrid Capture 2, cobas HPV test, PreservCyt, cervical intraepithelial neoplasia, sensitivity and specificity, co-testing, liquid-based cytology
- MeSH terms
- Uterine Cervical Neoplasms, Cervix Uteri, Cytodiagnosis, DNA, Viral, Female, Humans, Sensitivity and Specificity, Biomarkers, Papillomaviridae, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
